Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
11.18
+0.24 (2.19%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Beta Bionics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Cash & Equivalents
30.4326.5727.68
Short-Term Investments
73.1470.18-
Cash & Short-Term Investments
103.5896.7527.68
Cash Growth
7.06%249.58%-
Receivables
124.45-
Inventory
13.321.25-
Prepaid Expenses
2.980.910.54
Other Current Assets
1.050.280.25
Total Current Assets
132.92103.6228.47
Property, Plant & Equipment
11.426.26.87
Long-Term Deferred Charges
5.05--
Other Long-Term Assets
0.250.220.19
Total Assets
149.65110.0435.53
Accounts Payable
2.851.170.43
Accrued Expenses
13.337.076.14
Current Portion of Leases
1.531.220.98
Current Unearned Revenue
0.940.09-
Other Current Liabilities
2.51.051.32
Total Current Liabilities
21.1510.618.87
Long-Term Leases
5.7333.16
Long-Term Unearned Revenue
1.860.26-
Other Long-Term Liabilities
44.937.5710.5
Total Liabilities
73.6351.4322.53
Common Stock
000
Additional Paid-In Capital
51.3126.4215.53
Retained Earnings
-296.74-229.66-185.57
Comprehensive Income & Other
0.070.14-
Total Common Equity
-245.36-203.11-170.03
Shareholders' Equity
76.0158.6113
Total Liabilities & Equity
149.65110.0435.53
Total Debt
7.264.224.13
Net Cash (Debt)
96.3292.5223.54
Net Cash Growth
4.11%293.01%-
Net Cash Per Share
15.1317.444.71
Filing Date Shares Outstanding
43.355.035
Total Common Shares Outstanding
6.675.035
Working Capital
111.7893.0219.59
Book Value Per Share
-36.80-40.39-34.02
Tangible Book Value
-245.36-203.11-170.03
Tangible Book Value Per Share
-36.80-40.39-34.02
Machinery
7.485.785.56
Construction In Progress
1.740.170.18
Leasehold Improvements
0.810.950.95
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q